MMP2 was downregulated in papillary RCC in our analysis, but interestingly it has been shown that like MMP9, increased expression of MMP2 in RCC is an indicator of poor prognosis across subtypes (39). This evidence concerns the gene MMP9 and renal cell carcinoma.